Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8554 for Postoperative Pain
NCT05375305Phase 3Completed
- Sponsor
- Hengrui
- Start
- May 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegileridine in acute postoperative pain, sponsored by Hengrui. Started May 2022; status: completed.
02
Drugs
tegileridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT05375305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05375305.